Strong Q4 2024 Financial Performance and 2025 Outlook
February 6, 2025 - 17:33
In the fourth quarter of 2024, the company reported a remarkable 45% increase in revenue, reaching $13.53 billion. This surge was primarily fueled by significant volume growth from its flagship products, Mounjaro and Zepbound. The performance in this quarter showcases the company's robust market presence and the effectiveness of its growth strategies.
Additionally, non-incretin revenue experienced a solid 20% increase compared to the same period in 2023, reflecting the company's diverse portfolio and successful expansion into new therapeutic areas. The strong financial results indicate not only the popularity of its current offerings but also the potential for future growth.
Looking ahead, the company has provided guidance for 2025, emphasizing its commitment to innovation and market leadership. With a focus on enhancing product accessibility and exploring new opportunities, the company is well-positioned to sustain its momentum and deliver continued value to stakeholders in the coming year.
MORE NEWS
February 2, 2026 - 10:07
Hana Financial Group Seeks ‘Balanced Growth’ With Non-Bank TurnaroundHana Financial Group has announced a strategic pivot for the coming year, prioritizing a turnaround at its non-banking affiliates to achieve what it terms `balanced growth.` This move signals a...
February 1, 2026 - 19:29
I’m a 66-year-old retired homeowner in Fort Worth, sitting on $143,000 in cash. What should I do with my money?A retired homeowner in Fort Worth, aged 66, is thoughtfully considering the next steps for a substantial $143,000 cash reserve. This scenario highlights a common and crucial crossroads for many...
February 1, 2026 - 05:33
Bitcoin Retreats Below $80,000 as Market Sees Influx of New InvestorsThe price of Bitcoin has fallen below the psychologically significant $80,000 threshold, introducing a note of caution into the recent bullish market sentiment. This dip represents a period of...
January 31, 2026 - 06:28
Is Pathward Financial (CASH) Still Attractively Priced After Strong Recent Share Price GainsInvestors are closely examining Pathward Financial`s stock valuation after a period of significant share price appreciation. The financial services provider has delivered robust returns across...